MindMap Gallery Das Internet and Plans
This is a mind map about Das Internet and plans, including project summary, project background, finished product overview, business model, social value, development plan, project team, and financial analysis.
Edited at 2025-03-06 19:15:19Rumi: 10 dimensions of spiritual awakening. When you stop looking for yourself, you will find the entire universe because what you are looking for is also looking for you. Anything you do persevere every day can open a door to the depths of your spirit. In silence, I slipped into the secret realm, and I enjoyed everything to observe the magic around me, and didn't make any noise. Why do you like to crawl when you are born with wings? The soul has its own ears and can hear things that the mind cannot understand. Seek inward for the answer to everything, everything in the universe is in you. Lovers do not end up meeting somewhere, and there is no parting in this world. A wound is where light enters your heart.
Chronic heart failure is not just a problem of the speed of heart rate! It is caused by the decrease in myocardial contraction and diastolic function, which leads to insufficient cardiac output, which in turn causes congestion in the pulmonary circulation and congestion in the systemic circulation. From causes, inducement to compensation mechanisms, the pathophysiological processes of heart failure are complex and diverse. By controlling edema, reducing the heart's front and afterload, improving cardiac comfort function, and preventing and treating basic causes, we can effectively respond to this challenge. Only by understanding the mechanisms and clinical manifestations of heart failure and mastering prevention and treatment strategies can we better protect heart health.
Ischemia-reperfusion injury is a phenomenon that cellular function and metabolic disorders and structural damage will worsen after organs or tissues restore blood supply. Its main mechanisms include increased free radical generation, calcium overload, and the role of microvascular and leukocytes. The heart and brain are common damaged organs, manifested as changes in myocardial metabolism and ultrastructural changes, decreased cardiac function, etc. Prevention and control measures include removing free radicals, reducing calcium overload, improving metabolism and controlling reperfusion conditions, such as low sodium, low temperature, low pressure, etc. Understanding these mechanisms can help develop effective treatment options and alleviate ischemic injury.
Rumi: 10 dimensions of spiritual awakening. When you stop looking for yourself, you will find the entire universe because what you are looking for is also looking for you. Anything you do persevere every day can open a door to the depths of your spirit. In silence, I slipped into the secret realm, and I enjoyed everything to observe the magic around me, and didn't make any noise. Why do you like to crawl when you are born with wings? The soul has its own ears and can hear things that the mind cannot understand. Seek inward for the answer to everything, everything in the universe is in you. Lovers do not end up meeting somewhere, and there is no parting in this world. A wound is where light enters your heart.
Chronic heart failure is not just a problem of the speed of heart rate! It is caused by the decrease in myocardial contraction and diastolic function, which leads to insufficient cardiac output, which in turn causes congestion in the pulmonary circulation and congestion in the systemic circulation. From causes, inducement to compensation mechanisms, the pathophysiological processes of heart failure are complex and diverse. By controlling edema, reducing the heart's front and afterload, improving cardiac comfort function, and preventing and treating basic causes, we can effectively respond to this challenge. Only by understanding the mechanisms and clinical manifestations of heart failure and mastering prevention and treatment strategies can we better protect heart health.
Ischemia-reperfusion injury is a phenomenon that cellular function and metabolic disorders and structural damage will worsen after organs or tissues restore blood supply. Its main mechanisms include increased free radical generation, calcium overload, and the role of microvascular and leukocytes. The heart and brain are common damaged organs, manifested as changes in myocardial metabolism and ultrastructural changes, decreased cardiac function, etc. Prevention and control measures include removing free radicals, reducing calcium overload, improving metabolism and controlling reperfusion conditions, such as low sodium, low temperature, low pressure, etc. Understanding these mechanisms can help develop effective treatment options and alleviate ischemic injury.
International College Student Innovation Competition (2024) DUSBIOTECH Leader in front-end service of plant gene sequencing
Project Summary
Leader in front-end service of plant gene sequencing
Service content: Provide preliminary preparation and preliminary data processing services to ensure the accuracy and reliability of sequencing results.
Technical breakthrough: Team founder Shi Xianming proposed new gene detection technology and invented related products and services
Products and services: Plant DNA capacity detection kit, animal/plant DNA ploidy detection kit, plant flow cytometry analysis, etc.
Market monopoly: break the monopoly of foreign companies, form industrial strategic alliances, and sell front-end sequencing service business
A new challenge under the wave of "genome"
Policy support: From the 12th Five-Year Plan to the 14th Five-Year Plan, national policies support the development of gene sequencing technology.
Technical barriers: The development of high-end equipment and reagents faces high technical barriers and complex processes.
Market status: The growth rate of the domestic gene sequencing market is higher than that of the global market, but the upstream market is still monopolized overseas.
Plant gene sequencing products and services
Product price: The price of plant flow cytometry test kit is 1,000-3,500 yuan per time.
Technological innovation: quick leaf cutting, nuclear lysate, flow cytometry automatic injection tray, etc.
Service advantages: easy to operate, good safety, high sensitivity, high detection efficiency and affordable price.
Team Mission
Breaking the monopoly: Breaking the monopoly of foreign kits through professional technology and services.
Technical support: Provide technical support to small and micro enterprises and private enterprises to fill the gap in domestic plant gene sequencing needs.
The advantages and disadvantages of thinking under the current market environment
Advantages: Independent research and development, publish high-level papers, possess patented technology, easy to operate and affordable price.
Disadvantages: difficult technical operation, expensive equipment, restricted by regulations, and low public acceptance.
Gene sequencing market analysis
Market prospects: The global gene sequencing market is developing rapidly, and the Chinese market is gradually rising.
Market pain points: high technical barriers, difficult operation, and difficult innovation
Solution: Das develops new patented technologies to improve detection efficiency and accuracy and reduce costs.
Peer-to-peer marketing strategy
Marketing methods: point-to-point sales, Internet platform promotion, official website sales.
Customer group: scientific research institutions, biological enterprises, and university laboratories.
Business model
Model: Technology Service Product Sales.
Partners: Wuhan University, Northwest Hubei Medicinal Plant Laboratory, Wuhan Fraser, BGI.
Dasi’s “Three-step” strategic plan
Step 1: Establish a company, optimize the product, and complete the iteration of the testing reagent technology within 1 year.
Step 2: Horizontal expansion of business areas and add new histone extraction kits and other businesses within 3 years.
Step 3: Deep genetic sequencing development, becoming a leading front-end service company within 7 years.
Financial Analysis
Equity structure: The company's registered capital is 1 million yuan, Shi Xianming accounts for 40%, Ma Xueping and Yu Tingting each account for 30%.
Revenue forecast: revenue in the first year is 1 million, 2.5 million in the second year, and exceed 5 million in the third year.
11. Risk analysis and control
Patent risk: Improve confidentiality agreements and professional legal services.
Talent risk: Relying on universities to gather high-level talents.
Market risk: strong market competition and low product popularity.
Credit risk: kit accuracy issues.
Financial risk: inventory realization risk.
Brand risk: Increase popularity and expand influence.
Project background
Industry background
Genome wave: Since the human genome was successfully deciphered in the late 20th century, life science research has entered the "genome wave" stage.
Policy support: From the 12th Five-Year Plan to the 14th Five-Year Plan, national policies support the development of gene sequencing technology.
Market size: The global gene sequencing market is developing rapidly, and the Chinese market is gradually rising.
Technical background
Gene detection technology: Obtain genomic information of biological samples through genetic testing equipment and is applied to scientific research or clinical diagnosis.
Gene sequencing technology: The technology to obtain the base arrangement order of specific DNA fragments is the basis of molecular biology research and genetic modification.
Technology development: Gene sequencing technology has promoted the progress of genomics, biomedical research and clinical diagnosis.
Market background
Market status: The growth rate of domestic gene sequencers and consumables market is higher than the global average, but the upstream market is still monopolized overseas.
Technical barriers: The development of high-end equipment and reagents faces high technical barriers and complex processes.
Market demand: Gene sequencing technology has wide application prospects in personalized medical care, cancer treatment, reproductive health and other fields.
International competition: The global gene sequencer market is dominated by companies such as Illumina and Thermo Fisher. The domestic market is gradually rising but still relies on foreign technology.
Finished product overview
Product Introduction
Plant DNA volume detection kit: used to detect plant genome size, ploidy level, and cell cycle.
Service content: Provides plant DNA capacity detection kits and plant flow cytometry detection, flow ploidy analysis and plant chromosome counting and other services.
Product price and service price
Plant DNA capacity detection kit: 1000-3500 yuan per time.
Plant flow cytometry detection: 300 yuan per time.
Cell flow ploidy analysis technology: 300 yuan/time.
Plant chromosome count: RMB 2400-7900/sample.
Product Technology Innovation
Quick leaf cutting: Quickly process the sample to increase the concentration of nucleus in the lysate
Nuclear lysate: Achieve efficient and rapid nuclear lysis and improve the purity and yield of nucleic acid extraction.
Flow cytometry automatic injection tray: accurate limit, accurate injection.
How to use the product
Sample processing: collect the required samples to ensure the accuracy and reliability of the samples.
Mixing and reaction: Add the sample to the reagent and react thoroughly.
Measurement and analysis: Use the corresponding instrument to read the measurement results.
Cleaning and storage: Cleaning and disinfecting kits and utensils, storing unused reagents.
Product Advantages
Independent research and development: breaking the passive situation where plant DNA capacity detection kits are monopolized by foreign countries.
High cost performance: The price is much lower than that of foreign kits, and the quality of data reports is better than that of foreign ones.
Technical advantages: The scientific research team masters core technology without relying on third parties.
Significance of product innovation
Educational application: used for undergraduate flow cytometry teaching and experimental research, and enhance school-enterprise cooperation.
Scientific research application: Improve the efficiency of seed selection and breeding and assist scientific research institutions in research.
Corporate cooperation: Cooperate with biological enterprises to provide efficient technical services
Competitor Analysis
Potential competitors: weak entry ability and high technical barriers.
Alternatives: Weak substitution capability, flow cytometry detection is at the forefront.
Consumer bargaining power: weak bargaining power, strong targeted products, and scarce suppliers.
Business model
Business model canvas
Partners: Hubei Key Laboratory of Hubei Province Research on Special Chinese Medicine Hubei Province Medical Plant Comprehensive Utilization Engineering Technology Research Center Joint Innovation Center for the Development and Application of Endangered Rare Medicinal Plants in Wudang, Hubei Province Wuhan Fraser Gene Information Co., Ltd. BGI
Key business: Sales plant DNA capacity detection kits Provide front-end services for gene sequencing such as plant flow cytometry analysis, karyotyping analysis, chromosome counting, etc. Nanoantibody preparation business (to be developed) Cell histone extraction kits (under development)
Value Proposition: The scientific research team does not need to rely on third parties to master core technology, and the technology is not limited. Provide an overall solution for front-end plant gene sequencing services to simplify experimental steps. The kit can be applied to more than 90% of plants, breaking the barriers of foreign technology
Customer Relations: Win-win cooperation relationship Demand purchase relationship
Customer Segment: Research institutes and experimental universities Biomedical and genetic information enterprises Instrument and reagents and consumables trading companies
Core resources: Three key laboratories, six-person returnee doctoral team, eleven patented technology, four high-level papers, policy support, school platform channel access
Cost structure: R&D cost Product production cost Management cost Marketing cost
Operation process
R&D and production: The company develops and produces kits and products related to gene sequencing.
Sales and channels: Products are sold through multiple channels, including platform direct sales, strategic cooperation, universities and research institutes, etc.
Provide services: In addition to selling products, the company also provides genetic testing and analysis services, etc.
Strategic cooperation: Form a strategic alliance with BGI, Wuhan Fraser and other biological enterprises to purchase front-end testing business in batches.
Customized solutions: Provide personalized solutions and follow-up sequencing data according to customer needs.
Marketing Pricing Strategy
Product Pricing: Plant DNA capacity detection kit: 1000-3500 yuan/time Plant flow cytometry detection: 300 yuan/time Cell flow ploidy analysis technology: 300 yuan/time Plant chromosome count: Pricing based on the number of samples and chromosome count
New product pricing: Histone extraction kit: 600 yuan/50 times (estimated price)
Price Advantages: Compared with foreign test kits, the price is lower and the cost-effective
Marketing channel strategy
Direct sales: Directly connect with customers to save costs in the middle
Build and improve sales network: Expand the market through agents, raise funds quickly, and reduce financial risks
Sales Agency: Choose a powerful agent and establish long-term cooperative relationships
Marketing and promotional strategies
Media Promotion: Establish official websites, Weibo and WeChat platforms to promote publicity in professional publications and article reports
Personnel sales: Organize a high-quality marketing team to conduct door-to-door sales
Conference Sales: Participate in academic exchange meetings and seminars, conduct on-site product introduction and promotion
Public relations: Handle relationships with the public and establish a good brand image
After-sales service
Customer feedback mechanism: Establish a complete customer feedback channel, promptly handle customer needs and problems, questionnaire surveys and in-depth interviews and other methods Check users' real needs and suggestions for Dasi products. At the same time, real-time public opinion monitoring
Information exchange feedback platform: Build a platform for communication with customers to improve the response speed and processing efficiency of after-sales service, with the help of website messages, comments, and posts on forums. Reply.
Biological research enterprises
Social Value
Educational dimension
Integration of science and education to cultivate innovative talents: The team takes the front-end service of gene sequencing as the starting point to conduct research, build a scientific research platform, provide students with scientific research opportunities, and improve students' hands-on ability and problem-solving ability.
Integration of industry and education to improve students' comprehensive abilities and help schools build first-class courses: Through project cooperation, promote the construction of first-class curriculum in the school and provide students with high-quality scientific research and teaching platforms and technologies.
Multidisciplinary cross-teams, exchanges and cooperation promote the comprehensive development of members: Create a comprehensive team with multidisciplinary intersection to promote the comprehensive development of members
Establish a Wudang Chinese Herbal Molecular Center, and deeply integrate production, education and research: Establish a scientific research team in the discipline of molecular biology to promote the deep integration of industry, academia and research.
Help popularize science, carry forward local characteristics, and enhance the pride of hometown: Through popular science propaganda and other activities, increase the public's interest in science and enhance the sense of identity in my hometown.
Lead the development of the industry
Leading industry technology, giving birth to new forms of industry services: Launch a series of innovative products and services to break the monopoly of foreign companies in the market.
Create characteristic plant landmarks and increase the added value of traditional Chinese medicine: Help solve problems such as germplasm and high yield of characteristic plants and promote the high-quality development of the traditional Chinese medicinal materials industry.
Drive employment
Cooperating manufacturers increase their income and indirectly drive employment: The company's business development drives cooperative manufacturers to increase production demand and indirectly promote employment.
Recruiting employees, recruiting agents, and technology drives future scientific research and employment: After the company is established, recruit employees, recruit agents, and drive scientific research and employment.
Development Plan
Overall project strategy
Market and product expansion: The team will continue to expand in both market and product aspects. The market will be based on Hubei Province and gradually expand to central China. And ultimately cover the country.
Deeply cultivate the industrial chain: in-depth research and exploration of the field of genetic testing, Apply flow cytometry to a wider range of fields.
Comprehensive solution: provide comprehensive solutions to break the monopoly position of foreign kits. Establish a new standard for plant genome size detection.
Cross-omics services: Develop cross-omics services, launch histone extraction kits, and provide high-quality teaching aids for experimental universities. Help scientific research institutions to experiment and promote the development of biological enterprises.
Sustainable Development Strategy
Promotion of technological innovation: Continuously develop new cross-species products and sample preparation and other new services, Strengthen the introduction, digestion and absorption of mature and advanced technologies at home and abroad, and carry out innovative development.
Corporate core competitiveness: Strengthen the construction of corporate core competitiveness, strictly control quality, expand business, Form a lasting and unique corporate competitive advantage.
Strategic Partnership: Strengthen cooperative relations with universities, biological enterprises, scientific research institutions, etc., and continuously improve cooperative relations. Seek more strategic partners.
Project specific strategic planning
Phase 1 (2024-2025): Establish a company and optimize products
Company establishment: Plan to create Hubei Dasi Biotechnology Co., Ltd. in August 2024. Product development: Develop histone extraction kit based on DNA capacity kit. Team building: Strengthen team building and management, establish a good brand image, and create a professional and reliable brand reputation. Product update: Complete the 2.0 update of the test kit version and steadily expand the customer base.
Phase 2 (2025-2027): Horizontal expansion of business areas
New product launch: Histone extraction kit is expected to be officially launched in June 2025. Business expansion: Add nano-antibody preparation business, expand business areas, improve sales network, and achieve product enrichment and diversification. Application for high-tech enterprises: Apply for national high-tech enterprises.
Phase III (2027-2031): Development of In-depth Gene Sequencing
Technological breakthrough: break through the new generation of genetic markers, nucleic acid rapid detection related technology, and carry out research and development iteration of related technologies of various products.
Market expansion: Maintain the company's competitiveness, become a leading front-end service company, and establish cooperative relationships with many well-known biopharmaceutical companies.
Patents and Technology: Obtained 50 domestic and foreign patent authorizations and applications, covering the entire process module of the plant gene sequencing platform.
Popularization of applications: Accelerate clinical popularization, make breakthroughs in clinical application and drug selection in plant gene sequencing, and establish a rare plant quality control database.
Project Team
Team Overview
Team name: Hubei Dasi Biotechnology Co., Ltd. Established in May 2024 The team adopts a multidisciplinary cross-collaboration approach, combining expertise and technology in different fields, to promote innovation and all-round development.
Team organization structure
Scientific Research Department: Responsible for product research and development and technological innovation. Marketing Department: Responsible for market expansion and sales. Operations Department: Responsible for brand promotion and customer service. Administrative Department: Responsible for team management and financial work
Team management system
Reward system: Rewards are based on individual performance and contribution. Punishment system: Those who violate team rules and regulations are punished. Performance system: Performance assessment is conducted based on attendance, work performance, etc. Recruitment plan: recruit new members once a year and recruit new members through various channels.
Team member composition
Founder Team: Shi Xianming: Postgraduate student in the School of Basic Medicine, pathology and pathophysiology, and 6 years of experience in gene technology research and development. Ma Xueping: Postgraduate student at the School of Basic Medicine, Pathology and Pathophysiology, and five years of experience in medicinal plants research. Geng Lingjun: Basic Medicine - Postgraduate in Immunology, 3 years of experimental experience.
Expert technical team: You Lei: Ph.D. in biochemistry and molecular biology, presided over 3 scientific research projects. Li Chen: Director of the Hubei Cell Biology Society, won the first prize of Hubei Science and Technology Progress. Luo Xiangyin: Research direction of crop breeding, published many related papers.
Student Team: Department of Scientific Research: Ju Tingting, Zhang Mengying, Yu Tingting. Operation Department: Xu Qianqian, Jiang Shouhuan. Ministry of Administration: Zhong Luyao, Yang Zhili.
Expert guidance team: Zhang Yonghong: PhD in Biochemistry and Molecular Biology, Postdoctoral in Chemical Genetics. Xia Keke: Director of the Institute of Digital Earth, BGI Life Sciences Research Institute. Yi Xinxin: General Manager of Wuhan Fraser Gene Information Co., Ltd. Luo Ting: Senior marketing expert and SYB entrepreneurial mentor. Li Haitao: Director of the Entrepreneurship Center, lecturer of IYB and SYB.
Financial Analysis
Equity Structure Forecast
Company registered capital: RMB 1 million
Equity Structure:
Shi Xianming: 400,000 yuan, accounting for 40% of the shares Ma Xueping: 300,000 yuan, accounting for 30% of the shares Yu Tingting: 300,000 yuan, accounting for 30% of the shares
Current team revenue status
2024 (as of July):
Signed high-tech products/service units: RMB 1.2 million Prepayment: About 120,000 yuan
Early allocation of funds
Source of funds
Registered capital: 1 million yuan signed by the person in charge in the early stage Prepayment: About 200,000 yuan
Distribution ratio
Laboratory scientific research and instrumentation changes: 45% Operating funds after the establishment of the company: 25% Industry-university-research cooperation: 20% Product promotion cost: 10%
Main Finance
Tax preferential: Enterprises are exempt from income tax for two years from the year of profit, with income tax of 7.5% from the third to eighth years Surplus reserve: from the year of profit to 10% of net profit Dividend distribution: Distribute dividend bad debt provisions at 30% of net profit: accrued at 0.5% of current receivables Employee salary: Including various benefits and insurance costs
Cost and cost estimates
Production cost: 2024: 677,000 yuan 2025: 1.38 million yuan 2026: 2.416 million yuan
Management and maintenance costs: 2024: 25,000 yuan 2025: 38,000 yuan 2026: 79,000 yuan
Financial expenses: 2024: 11,000 yuan 2025: 26,000 yuan 2026: 58,000 yuan
Company revenue forecast
2024: Estimated revenue to reach 1 million yuan 2025: Estimated revenue to reach 2.5 million yuan 2026: The cumulative revenue is expected to exceed 5 million yuan
Return and exit mechanism of venture capital
Return on investment of venture capital: Account for 41.81% of Das Equity. Participate in dividends since profits, and the total dividends distributed annually are 20% of net profits.
Exit mechanism:
Mergers and Acquisitions: Recover all risky funds through property transfer Share repurchase: Calculate corporate value by multiplying the annual net profit at the time of exit by the price-to-earnings ratio IPO Listed on GEM: The company chooses to go public after successfully achieving diversified production and stock system transformation
Patented technology and devices
Authorized utility model patents (5 items)
A quick leaf cutting
Function: It consists mainly of a handle and a blade, which is similar to a syringe, including a hollow tubular handle barrel and a piston rod. There are multiple blade slots and water outlet holes at the bottom of the handle barrel, and a flow guide groove is provided on the blade. The lysate can slide from the handle barrel to the blade to flow out, which facilitates sufficient infiltration of the blade, improves the concentration of the cell nucleus in the lysate and improves the success rate. It is safer to not directly contact the blade. The blades can be divided into small blades with uniform spacing, and adding lysate to the handle barrel can save the amount.
Application: Simple operation, good sample processing effect, can greatly improve success rate, save time and money, and can be designed as blade cut of different specifications to reduce human error.
Gynostem blue cleaning and drying device
A kind of cooling platform for gynostem blue
A finished product harvesting device for gynostemum blue
A Gynostem blue cultivation box
Authorized invention patents (2 items)
A plant flow cytonuclear dissociation solution and its application
A plant flow cytonuclear dissociation solution based on sodium cocoyl glycine and NP-40 and its application
Application of invention patent (accepted) (4 items)
A flow cytometer with good protection performance
A flow cytometer automatic injection tray
An integrated device for chromosomal karyotyping analysis and counting
A sample filtration device for flow cytometry